← USPTO Patent Applications

COMPOSITIONS COMPRISING MODIFIED, TRUNCATED GLCNAC-1-PHOSPHOTRANSFERASE

Application US20260092263A1 Kind: A1 Apr 02, 2026

Inventors

Lin LIU, Andrew Charles HEDMAN

Abstract

Provided are amino acid sequences for modified, truncated forms of human GlcNA-1-Phosphotransferase (PTase) that retain phosphotransferase activity and the ability to phosphorylate proteins, lysosomal or non-lysosomal. Truncated forms of PTase lacking or with modified linkers and/or lacking the C-terminal transmembrane and cytosolic domain are demonstrated to retain phosphotransferase activity and the ability to phosphorylate target proteins.

CPC Classifications

C12N 9/1288 C12N 15/8645 C12Y 207/07049 C12N 2750/14143

Filing Date

2025-08-04

Application No.

19289364